Status:
COMPLETED
Ayahuasca and Esketamine for Major Depression
Lead Sponsor:
University of Sao Paulo
Conditions:
Major Depression Severe
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Double-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.
Eligibility Criteria
Inclusion
- \- Clinical diagnosis of depressive disorder
Exclusion
- \- Presence of psychiatric and other medical comorbidities
Key Trial Info
Start Date :
October 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT07212946
Start Date
October 30 2022
End Date
October 1 2025
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo, Brazil, 14049900